These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 21194034)
1. Local gene delivery and methods to control immune responses in muscles of normal and dystrophic dogs. Wang Z; Tapscott SJ; Storb R Methods Mol Biol; 2011; 709():265-75. PubMed ID: 21194034 [TBL] [Abstract][Full Text] [Related]
2. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Wang Z; Kuhr CS; Allen JM; Blankinship M; Gregorevic P; Chamberlain JS; Tapscott SJ; Storb R Mol Ther; 2007 Jun; 15(6):1160-6. PubMed ID: 17426713 [TBL] [Abstract][Full Text] [Related]
3. Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model. Wang Z; Halbert CL; Lee D; Butts T; Tapscott SJ; Storb R; Miller AD Gene Ther; 2014 Apr; 21(4):363-70. PubMed ID: 24500525 [TBL] [Abstract][Full Text] [Related]
4. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597 [TBL] [Abstract][Full Text] [Related]
5. Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. Wang Z; Allen JM; Riddell SR; Gregorevic P; Storb R; Tapscott SJ; Chamberlain JS; Kuhr CS Hum Gene Ther; 2007 Jan; 18(1):18-26. PubMed ID: 17176210 [TBL] [Abstract][Full Text] [Related]
6. Humoral immunity to AAV-6, 8, and 9 in normal and dystrophic dogs. Shin JH; Yue Y; Smith B; Duan D Hum Gene Ther; 2012 Mar; 23(3):287-94. PubMed ID: 22040468 [TBL] [Abstract][Full Text] [Related]
7. A simplified immune suppression scheme leads to persistent micro-dystrophin expression in Duchenne muscular dystrophy dogs. Shin JH; Yue Y; Srivastava A; Smith B; Lai Y; Duan D Hum Gene Ther; 2012 Feb; 23(2):202-9. PubMed ID: 21967249 [TBL] [Abstract][Full Text] [Related]
8. Whole body skeletal muscle transduction in neonatal dogs with AAV-9. Yue Y; Shin JH; Duan D Methods Mol Biol; 2011; 709():313-29. PubMed ID: 21194038 [TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610 [TBL] [Abstract][Full Text] [Related]
10. Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone. Cramer ML; Shao G; Rodino-Klapac LR; Chicoine LG; Martin PT Hum Gene Ther; 2017 Jun; 28(6):493-509. PubMed ID: 28345428 [TBL] [Abstract][Full Text] [Related]
11. Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle. Ohshima S; Shin JH; Yuasa K; Nishiyama A; Kira J; Okada T; Takeda S Mol Ther; 2009 Jan; 17(1):73-80. PubMed ID: 18941441 [TBL] [Abstract][Full Text] [Related]
12. Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus. Yue Y; Pan X; Hakim CH; Kodippili K; Zhang K; Shin JH; Yang HT; McDonald T; Duan D Hum Mol Genet; 2015 Oct; 24(20):5880-90. PubMed ID: 26264580 [TBL] [Abstract][Full Text] [Related]
14. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413 [TBL] [Abstract][Full Text] [Related]
15. Systemic gene transfer to skeletal muscle using reengineered AAV vectors. Phillips JL; Hegge J; Wolff JA; Samulski RJ; Asokan A Methods Mol Biol; 2011; 709():141-51. PubMed ID: 21194026 [TBL] [Abstract][Full Text] [Related]
16. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy. Le Guiner C; Servais L; Montus M; Larcher T; Fraysse B; Moullec S; Allais M; François V; Dutilleul M; Malerba A; Koo T; Thibaut JL; Matot B; Devaux M; Le Duff J; Deschamps JY; Barthelemy I; Blot S; Testault I; Wahbi K; Ederhy S; Martin S; Veron P; Georger C; Athanasopoulos T; Masurier C; Mingozzi F; Carlier P; Gjata B; Hogrel JY; Adjali O; Mavilio F; Voit T; Moullier P; Dickson G Nat Commun; 2017 Jul; 8():16105. PubMed ID: 28742067 [TBL] [Abstract][Full Text] [Related]
17. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice. Koo T; Popplewell L; Athanasopoulos T; Dickson G Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945 [TBL] [Abstract][Full Text] [Related]
18. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685 [TBL] [Abstract][Full Text] [Related]
19. AAV-mediated gene therapy to the isolated limb in rhesus macaques. Rodino-Klapac LR; Montgomery CL; Mendell JR; Chicoine LG Methods Mol Biol; 2011; 709():287-98. PubMed ID: 21194036 [TBL] [Abstract][Full Text] [Related]
20. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation. Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]